Genomics
Genomics provides a genetic data science platform that uses polygenic risk scores and DNA analysis to predict an individual's risk of common diseases. The company serves pharmaceutical firms by accelerating drug discovery and clinical trial design, while also offering risk stratification tools to healthcare systems, employers, and insurance partners. Their technology utilizes population-scale genetic databases to enable precision health screening and the identification of novel biomarkers.
Software
Biotechnology
Healthcare
Life Sciences
Healthtech
Funding summary
- Total raised
- €28.3M
- Funding rounds
- 1
Investors in Genomics
Investors on record for Genomics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Genomics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors